1BC‐ bronchial carcinoid; 2 Consider additional testing based on clinical concern for paraneoplastic syndromes: Carcinoid syndrome (24‐hour urine 5‐HIAA), acromegaly (serum IGF‐1), Cushing's Syndrome (salivary cortisol, 24‐hour urine cortisol, dexamethasone suppression test); 3 SSA‐ somatostatin analog; 4 PRRT‐ peptide receptor radionuclide therapy. This evidence concerns the gene IGF1 and carcinoid syndrome.